[Reproducibility of histological criteria of dysplasia in Barrett mucosa]
- PMID: 8013780
[Reproducibility of histological criteria of dysplasia in Barrett mucosa]
Abstract
Barrett's mucosa is a precancerous condition. The goal of endoscopic surveillance for patients with Barrett's esophagus is to grade dysplasia. The diagnosis of dysplasia is difficult. The aim of this study was to determine the observer variation in diagnosis of dysplasia. Thirty-seven biopsies selected from Barrett's mucosa reported as having dysplasia between 1987 and 1988 were reviewed by 4 pathologists. The biopsies were classified according to the method of Riddell, as no dysplasia, indefinite for dysplasia, low-grade dysplasia and high-grade dysplasia. Each pathologist reviewed the biopsies alone and then together. There was a total agreement between the 4 pathologists in 20 out of 37 biopsies (54%). The pair-wise agreement varied between 65 and 84%. It was 84% when the pathologists belonged to the same institution. Of 222 double reviews made by 6 pairs of pathologists (37 biopsies x 6 pairs of pathologists), there were 58 disagreements: 19 low grade/high grade dysplasia, 2 high grade/indefinite for dysplasia, 1 high grade/no dysplasia, 18 low grade/indefinite for dysplasia, 2 low grade/no dysplasia, 16 indefinite for dysplasia/no dysplasia. At the second review when the pathologists evaluated the biopsies together, the agreement was 92%; there were 3 biopsies on which there was total disagreement: twice between high grade and low grade dysplasia, once between low grade dysplasia, indefinite for dysplasia and no dysplasia. This retrospective study has shown that disagreement between pathologists was rarely found on the biopsies diagnosed as having high grade dysplasia, more often on those diagnosed as having low grade dysplasia or indefinite for dysplasia.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies.Am J Gastroenterol. 2008 Sep;103(9):2333-40; quiz 2341. doi: 10.1111/j.1572-0241.2008.02020.x. Epub 2008 Jul 30. Am J Gastroenterol. 2008. PMID: 18671819
-
The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.Am J Gastroenterol. 2000 Dec;95(12):3383-7. doi: 10.1111/j.1572-0241.2000.03348.x. Am J Gastroenterol. 2000. PMID: 11151865
-
Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.Endoscopy. 2006 Dec;38(12):1206-12. doi: 10.1055/s-2006-944974. Endoscopy. 2006. PMID: 17163320
-
[Flow cytometric analysis of cellular DNA content in Barret's esophagus. A study of 66 cases].Gastroenterol Clin Biol. 1991;15(10):703-10. Gastroenterol Clin Biol. 1991. PMID: 1816011 Review. French.
-
Histology of metaplasia and dysplasia in Barrett's esophagus.Surg Oncol Clin N Am. 2009 Jul;18(3):411-22. doi: 10.1016/j.soc.2009.03.011. Surg Oncol Clin N Am. 2009. PMID: 19500733 Review.
Cited by
-
Time gated fluorescence spectroscopy in Barrett's oesophagus.Gut. 2003 Jan;52(1):28-33. doi: 10.1136/gut.52.1.28. Gut. 2003. PMID: 12477755 Free PMC article.
-
A cost-utility analysis of ablative therapy for Barrett's esophagus.Gastroenterology. 2009 Jun;136(7):2101-2114.e1-6. doi: 10.1053/j.gastro.2009.02.062. Epub 2009 Mar 6. Gastroenterology. 2009. PMID: 19272389 Free PMC article. Review.
-
Routine morphometrical analysis can improve reproducibility of dysplasia grade in Barrett's oesophagus surveillance biopsies.J Clin Pathol. 2002 Dec;55(12):910-6. doi: 10.1136/jcp.55.12.910. J Clin Pathol. 2002. PMID: 12461055 Free PMC article.
-
Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.Am J Gastroenterol. 2001 Oct;96(10):2839-48. doi: 10.1111/j.1572-0241.2001.04236.x. Am J Gastroenterol. 2001. PMID: 11693316 Free PMC article.
-
Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables.Am J Gastroenterol. 2001 Nov;96(11):3071-83. doi: 10.1111/j.1572-0241.2001.05261.x. Am J Gastroenterol. 2001. PMID: 11721752 Free PMC article.